Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1Q1K

Structure of ATP-phosphoribosyltransferase from E. coli complexed with PR-ATP

Summary for 1Q1K
Entry DOI10.2210/pdb1q1k/pdb
DescriptorATP phosphoribosyltransferase, PHOSPHORIBOSYL ATP, L(+)-TARTARIC ACID (3 entities in total)
Functional Keywordshistidine biosynthesis, prpp binding, pr-atp inhibition, transferase
Biological sourceEscherichia coli
Cellular locationCytoplasm: P60757
Total number of polymer chains1
Total formula weight34428.20
Authors
Lohkamp, B.,McDermott, G.,Coggins, J.R.,Lapthorn, A.J. (deposition date: 2003-07-21, release date: 2004-03-02, Last modification date: 2024-12-25)
Primary citationLohkamp, B.,McDermott, G.,Campbell, S.A.,Coggins, J.R.,Lapthorn, A.J.
The structure of Escherichia coli ATP-phosphoribosyltransferase: identification of substrate binding sites and mode of AMP inhibition
J.Mol.Biol., 336:131-144, 2004
Cited by
PubMed Abstract: ATP-phosphoribosyltransferase (ATP-PRT), the first enzyme of the histidine pathway, is a complex allosterically regulated enzyme, which controls the flow of intermediates through this biosynthetic pathway. The crystal structures of Escherichia coli ATP-PRT have been solved in complex with the inhibitor AMP at 2.7A and with product PR-ATP at 2.9A (the ribosyl-triphosphate could not be resolved). On the basis of binding of AMP and PR-ATP and comparison with type I PRTs, the PRPP and parts of the ATP-binding site are identified. These structures clearly identify the AMP as binding in the 5-phosphoribosyl-alpha-1-pyrophosphate (PRPP)-binding site, with the adenosine ring occupying the ATP-binding site. Comparison with the recently solved Mycobacterium tuberculosis ATP-PRT structures indicates that histidine is solely responsible for the large conformational changes observed between the hexameric forms of the enzyme. The role of oligomerisation in inhibition and the structural basis for the synergistic inhibition by histidine and AMP are discussed.
PubMed: 14741209
DOI: 10.1016/j.jmb.2003.12.020
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.9 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon